Head and Neck Adenocarcinoma — Trials

Head and Neck Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

213 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 47
Recruiting: 19
Ph III recruiting: 4
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07072676	The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.(Risk of fall)	enrolling by invitation	N/A	30	LMU KlinikumOTHER	1	Jul 18, 2025	clinicaltrials

Data updated 22 days agoSource updated Jul 18, 2025source: clinicaltrials